Transcervical Versus Laparotomy Embryo Recovery: What Strategy Is Best for Embryo Bank Formation in the Canindé Goat Conservation Program?

Author(s):  
Joanna M.G. Souza-Fabjan ◽  
Ribrio I.T.P. Batista ◽  
Luciana M. Melo ◽  
Marcos A.L. Oliveira ◽  
Maiana S. Chaves ◽  
...  
Animals ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 216
Author(s):  
Hernan Baldassarre

The potential of laparoscopic ovum pick-up (LOPU) followed by in vitro embryo production (IVEP) as a tool for accelerated genetic programs in ruminants is reviewed in this article. In sheep and goats, the LOPU-IVEP platform offers the possibility of producing more offspring from elite females, as the procedure is minimally invasive and can be repeated more times and more frequently in the same animals compared with conventional surgical embryo recovery. On average, ~10 and ~14 viable oocytes are recovered by LOPU from sheep and goats, respectively, which results in 3–5 transferable embryos and >50% pregnancy rate after transfer. LOPU-IVEP has also been applied to prepubertal ruminants of 2–6 months of age, including bovine and buffalo calves. In dairy cattle, the technology has gained momentum in the past few years stemming from the development of genetic marker selection that has allowed predicting the production phenotype of dairy females from shortly after birth. In Holstein calves, we obtained an average of ~22 viable oocytes and ~20% transferable blastocyst rate, followed by >50% pregnancy rate after transfer, declaring the platform ready for commercial application. The present and future of this technology are discussed with a focus on improvements and research needed.


2021 ◽  
pp. 106441
Author(s):  
Monique de Albuquerque Lagares ◽  
Fabiana Cristina Varago ◽  
Valéria Spyridion Moustacas ◽  
Valentim Arabicano Gheller ◽  
Rafael Romero Nicolino ◽  
...  

2000 ◽  
Vol 29 (1) ◽  
pp. 52-58 ◽  
Author(s):  
Ilmari V. Pyykkö ◽  
Esko M. Toppila ◽  
Jukka P. Starck ◽  
Martti Juhola ◽  
Yrjö Auramo

2012 ◽  
Vol 170 (2) ◽  
pp. 60-60 ◽  
Author(s):  
A. Pinna ◽  
G. Martins ◽  
W. Lilenbaum

Zygote ◽  
2004 ◽  
Vol 12 (3) ◽  
pp. 257-261 ◽  
Author(s):  
Hernan Baldassarre ◽  
Bin Wang ◽  
Melanie Gauthier ◽  
Nathalie Neveu ◽  
Anthoula Lazaris ◽  
...  

This study was aimed at developing a hormonal treatment protocol in order to optimize the proportion of pronuclear-stage embryos to be used for DNA microinjection in a goat transgenic founder production programme. A total of 46 adult BELE® and 47 adult standard goats (1–5 years old) were used as donors and recipients, respectively. They were heat-synchronized using intravaginal sponges containing 60 mg medroxyprogesterone acetate for 10 days with an injection of 125 μg cloprostenol on the morning of the eighth day. Recipients were injected with 400 IU eCG at the time of sponge removal while donors received a total of 133 mg NIH-FSH-P1 (Folltropin-V) given twice daily in decreasing doses over 3 days starting 48 h before sponge removal. Ovulation was induced in donors by injecting 100 μg of GnRH at 24 h (GnRH24) or 36 h (GnRH36) after sponge removal. Embryo recovery was performed by oviduct flushing following a standard mid-ventral laparotomy procedure. The proportion of embryos in the pronuclear stage of development was higher in the GnRH36 group (90% vs 34%, p<0.01). Embryos were microinjected with a DNA expression cassette followed by transfer to the oviduct of synchronized recipients. A higher, yet not statistically significant, pregnancy rate was found in the recipients transferred with pronuclear-stage embryos compared with those transferred with 2-cell-stage embryos (64% vs 37%, chi-square p=0.06). One transgenic female founder was produced from the group of recipients transferred with pronuclear-stage microinjected embryos.


Sign in / Sign up

Export Citation Format

Share Document